Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Debt to Equity: 2017-2023

Historic Debt to Equity for Organogenesis Holdings (ORGO) over the last 7 years, with Dec 2023 value amounting to $0.24.

  • Organogenesis Holdings' Debt to Equity fell 8.67% to $0.22 in Q3 2024 from the same period last year, while for Sep 2024 it was $0.92, marking a year-over-year decrease of 7.96%. This contributed to the annual value of $0.24 for FY2023, which is 10.78% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Debt to Equity of $0.24 as of FY2023, which was down 10.78% from $0.27 recorded in FY2022.
  • Organogenesis Holdings' 5-year Debt to Equity high stood at $4.26 for FY2019, and its period low was $0.24 during FY2023.
  • For the 3-year period, Organogenesis Holdings' Debt to Equity averaged around $0.27, with its median value being $0.27 (2022).
  • Its Debt to Equity has fluctuated over the past 5 years, first surged by 46.86% in 2019, then slumped by 45.00% in 2020.
  • Organogenesis Holdings' Debt to Equity (Yearly) stood at $1.37 in 2019, then reached $1.93 in 2019, then reached $4.26 in 2019, then soared by 46.86% to $0.98 in 2019, then slumped by 45.00% to $0.54 in 2020, then plummeted by 43.72% to $0.30 in 2021, then dropped by 12.45% to $0.27 in 2022, then dropped by 10.78% to $0.24 in 2023.